- Home
- TOMZ vs BRTX Comparison
TOMZ vs BRTX Comparison
Compare TOMZ & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- BRTX
- Stock Information
- Founded
- TOMZ 1979
- BRTX 1997
- Country
- TOMZ United States
- BRTX United States
- Employees
- TOMZ N/A
- BRTX N/A
- Industry
- TOMZ Diversified Commercial Services
- BRTX Managed Health Care
- Sector
- TOMZ Finance
- BRTX Health Care
- Exchange
- TOMZ Nasdaq
- BRTX Nasdaq
- Market Cap
- TOMZ 16.0M
- BRTX 13.7M
- IPO Year
- TOMZ N/A
- BRTX N/A
- Fundamental
- Price
- TOMZ $1.13
- BRTX $1.78
- Analyst Decision
- TOMZ Strong Buy
- BRTX Strong Buy
- Analyst Count
- TOMZ 1
- BRTX 1
- Target Price
- TOMZ $3.50
- BRTX $18.00
- AVG Volume (30 Days)
- TOMZ 32.9K
- BRTX 27.4K
- Earning Date
- TOMZ 05-08-2025
- BRTX 05-14-2025
- Dividend Yield
- TOMZ N/A
- BRTX N/A
- EPS Growth
- TOMZ N/A
- BRTX N/A
- EPS
- TOMZ N/A
- BRTX N/A
- Revenue
- TOMZ $8,201,313.00
- BRTX $391,000.00
- Revenue This Year
- TOMZ $3.66
- BRTX $391.52
- Revenue Next Year
- TOMZ $139.63
- BRTX $3.50
- P/E Ratio
- TOMZ N/A
- BRTX N/A
- Revenue Growth
- TOMZ 19.09
- BRTX 161.54
- 52 Week Low
- TOMZ $0.60
- BRTX $1.03
- 52 Week High
- TOMZ $1.50
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- TOMZ 74.11
- BRTX 52.54
- Support Level
- TOMZ $1.09
- BRTX $1.68
- Resistance Level
- TOMZ $1.20
- BRTX $1.79
- Average True Range (ATR)
- TOMZ 0.07
- BRTX 0.06
- MACD
- TOMZ 0.04
- BRTX 0.01
- Stochastic Oscillator
- TOMZ 90.88
- BRTX 79.31
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.